Concepedia

Ivan Ranđelović

IR

Statistics

Publications

15

Citations

352

H-Index

13

Active since

2013

Affiliations

National Institute of Oncology(Current)

Eötvös Loránd University

Semmelweis University

Hungarian Academy of Sciences

Budapest University of Technology and Economics

Ivan Ranđelović is an author at National Institute of Oncology specializing in medicine, biomolecular engineering, and pharmacology.

ORCID

Top concepts

Publications per year

2013–2024

15

Publications

15

Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity

Anja Gronewold, Mareike Horn, Ivan Ranđelović et al. · ChemMedChem · 2016 · 52 citations · Full text

In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery

Andrea Angelo Pierluigi Tripodi, Ivan Ranđelović, Beáta Biri‐Kovács et al. · Pathology & Oncology Research · 2019 · 33 citations · Full text

Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer

Levente Dókus, Eszter Lajkó, Ivan Ranđelović et al. · Pharmaceutics · 2020 · 31 citations · Full text

Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x = 0–2) ligands

Gerd Ludwig, Sanja Mijatović, Ivan Ranđelović et al. · European Journal of Medicinal Chemistry · 2013 · 28 citations

, , +7

Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice

Ivan Ranđelović, Sabine Schuster, Bence Kapuvári et al. · International Journal of Molecular Sciences · 2019 · 28 citations · Full text

1–5 of 15